Bliss GVS Pharma Limited (NSE:BLISSGVS)
447.20
-20.40 (-4.36%)
Jul 22, 2026, 3:30 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 49.55 billion as of July 22, 2026. Its market cap has increased by 191.17% in one year.
Market Cap
49.55B
Enterprise Value
48.27B
Revenue
9.27B
Ranking
n/a
PE Ratio
38.38
Stock Price
447.20
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 49.55B, an increase of 492,887.17%. That is a compound annual growth rate of 41.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 49.55B | 186.50% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 101.81B |
| Strides Pharma Science | 99.08B |
| Sudeep Pharma | 97.45B |
| Sun Pharma Advanced Research Company | 76.33B |
| Aarti Pharmalabs | 64.18B |
| Innova Captab | 55.09B |
| Orchid Pharma | 52.82B |
| RPG Life Sciences | 47.30B |